Código QR

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, Qatar University, PO Box 2713,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zolezzi M, Abouelhassan R, Eltorki Y, Haddad PM, Noorizadeh M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	intramuscular preparations depot antipsychotics injection site adverse effects Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/fe95571e0823467983a83e86dafadb3d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Recommendation of the Best Site Based on the Distribution Pattern of Extramuscular and Intramusular Nerves for Gluteal Muscle Injection
por: Wu,Junxi, et al.
Publicado: (2020)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
por: Suda A, et al.
Publicado: (2018)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni C, et al.
Publicado: (2016)

Pain from intramuscular vaccine injection in adults
por: Sahngun Nahm,Francis, et al.
Publicado: (2012)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019)

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study
por: Chiu LL, et al.
Publicado: (2019)

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini F, et al.
Publicado: (2019)

Discrepancy in Taiwanese psychiatrists’ preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey
por: Liu CH, et al.
Publicado: (2018)

Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection
por: Fitzgerald HM, et al.
Publicado: (2021)

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia
por: Ohnishi T, et al.
Publicado: (2021)

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
por: Sajatovic M, et al.
Publicado: (2018)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic M, et al.
Publicado: (2018)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Stephan Hjorth, et al.
Publicado: (2021)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: Birgit Sadoghi, et al.
Publicado: (2021)

Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir S, et al.
Publicado: (2016)

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
por: Hýža M, et al.
Publicado: (2021)

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
por: de Bartolomeis A, et al.
Publicado: (2016)

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Chih-Sung Liang, et al.
Publicado: (2021)

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
por: Such P, et al.
Publicado: (2021)

The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
por: Li F, et al.
Publicado: (2019)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
por: Salzman PM, et al.
Publicado: (2017)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: JP Lindenmayer
Publicado: (2010)

Description of a Feline Injection-Site Fibrosarcoma with Metastasis in the Cerebellum
por: Cora Roxana, et al.
Publicado: (2017)

Assessment of Antipsychotic Medications on Social Media: Machine Learning Study
por: Miguel A. Alvarez-Mon, et al.
Publicado: (2021)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
por: Leonid Mikhaylovich Bardenshteyn, et al.
Publicado: (2010)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Rachael K. Blackman, et al.
Publicado: (2022)

The Youth and Childhood Adversity Scale: a step towards developing a new measure of adversity and its severity
por: Pascal Schlechter, et al.
Publicado: (2021)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome L, et al.
Publicado: (2021)

Use of atypical antipsychotics in the elderly: a clinical review
por: Gareri P, et al.
Publicado: (2014)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Dhiren Singh, et al.
Publicado: (2009)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen Y, et al.
Publicado: (2019)

Large-Eddy Simulation of Laser-Ignited Direct Injection Gasoline Spray for Emission Control
por: Fabien Tagliante, et al.
Publicado: (2021)

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
por: Brasso C, et al.
Publicado: (2017)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Ping Yin, et al.
Publicado: (2021)

The efficacy of antipsychotics for prolonged delirium with renal dysfunction
por: Asano S, et al.
Publicado: (2017)

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life
por: Cuomo I, et al.
Publicado: (2018)

Effects of soil cultivation, fertilisation, initial seedling diameter and plant handling on the development of maturing Pinus radiata D. Don on Kaingaroa gravelly sand in the Central North Island of New Zealand
por: MASON,EUAN G
Publicado: (2004)

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
por: Kiwan N, et al.
Publicado: (2019)

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
por: Dayabandara M, et al.
Publicado: (2017)

Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
por: Natalia N. Petrova, et al.
Publicado: (2020)